Standardizing the measurement of parasite clearance in falciparum malaria: The parasite clearance estimator

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Flegg, Jennifer A ^a   Guerin, Philippe J ^a   White, Nicholas J ^b   Stepniewska, Kasia ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

drug resistance; malaria; parasite clearance, artemisinin resistance; regression analysis

Indexed keywords

ARTEMISININ DERIVATIVE; ANTIMALARIAL AGENT; ARTESUNATE;

ACCURACY; ARTICLE; GROWTH CURVE; MALARIA FALCIPARUM; METHODOLOGY; MICROBIAL COMMUNITY; NONHUMAN; PARASITE CLEARANCE; PARASITEMIA; RELIABILITY; STANDARDIZATION; VALIDATION STUDY; BLOOD; CAMBODIA; EVALUATION; HUMAN; ISOLATION AND PURIFICATION; PARASITE LOAD; PARASITOLOGY; PLASMODIUM FALCIPARUM; STANDARD;

ANTIMALARIALS; ARTEMISININS; BLOOD; CAMBODIA; HUMANS; MALARIA, FALCIPARUM; PARASITE LOAD; PARASITEMIA; PLASMODIUM FALCIPARUM;

EID: 80755143047     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-339     Document Type: Article

References (21)

1. Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Guerin P, Olliaro P, Nosten F, Druilhe P, Laxminarayan R, Binka F, Kilama W, Ford N, White N, Lancet Infect Dis 2002 2 564 573 10.1016/S1473-3099(02)00372-9 12206972 (Pubitemid 34966359)
2. Field-based evidence of fast and global increase of Plasmodium falciparum drug-resistance by DNA-microarrays and PCR/RFLP in Niger. Ibrahim M, Steenkeste N, Khim N, Adam H, Konaté L, Coppée J, Ariey F, Duchemin J, Malar J 2009 8 32 10.1186/1475-2875-8-32 19236701
3. World Health Organization, Guidelines for the treatment of malaria, second edition World Health Organization, Geneva 2010
4. Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Noedl H, Se Y, Sriwichai S, Schaecher K, Teja-Isavadharm P, Smith B, Rutvisuttinunt W, Bethell D, Surasri S, Fukuda MM, Clin Infect Dis 2010 51 82 10.1086/657120 21028985
5. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
6. World Health Organization, Global plan for artemisinin resistance containment (GPARC) World Health Organization, Geneva 2011
7. Evidence of artemisinin-resistant malaria in western Cambodia. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
8. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Rogers W, Sem R, Tero T, Chim P, Lim P, Muth S, Socheat D, Ariey F, Wongsrichanalai C, Malar J 2009 8 10 10.1186/1475-2875-8-10 19138388
9. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. Carrara VI, Zwang J, Ashley EA, Price RN, Stepniewska K, Barends M, Brockman A, Anderson T, McGready R, Phaiphun L, PLoS ONE 2009 4 4551 10.1371/journal.pone. 0004551 19234601
10. Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum. Imwong M, Dondorp AM, Nosten F, Yi P, Mungthin M, Hanchana S, Das D, Phyo AP, Lwin KM, Pukrittayakamee S, Antimicrob Agents Chemother 2010 54 7 2886 10.1128/AAC.00032-10 20421395
11. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. White NJ, Antimicrob Agents Chemother 1997 41 1413 1422 9210658 (Pubitemid 27289660)
12. The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria. Chotivanich K, Udomsangpetch R, Dondorp A, Williams T, Angus B, Simpson J, Pukrittayakamee S, Looareesuwan S, Newbold C, White N, J Infect Dis 2000 182 629 10.1086/315718 10915102 (Pubitemid 30651065)
13. In vivo parasitological measures of artemisinin susceptibility. Stepniewska K, Ashley E, Lees S, Anstey N, Barnes K, Quang Binh T, D'Alessandro U, Day N, de Vries P, Dorsey G, J Infect Dis 2010 201 570 579 10.1086/650301 20085495
14. The parasite clearance curve. White NJ, Malar J 2011 10 278 10.1186/1475-2875-10-278 21939506
15. Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria. Silamut K, White N, Trans R Soc Trop Med Hyg 1993 87 436 443 10.1016/0035-9203(93)90028-O 8249075
16. The effects of multiplication and synchronicity on the vascular distribution of parasites in falciparum malaria. White N, Chapman D, Watt G, Trans R Soc Trop Med Hyg 1992 86 590 597 10.1016/0035-9203(92)90141-X 1287908 (Pubitemid 23012896)
17. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, Lee SJ, Dondorp AM, White LJ, Day NP, et al. Malar J 2009 8 253 10.1186/1475-2875-8-253 19906307
18. Clearance kinetics of parasites and pigment-containing leukocytes in severe malaria. Day NP, Pham TD, Phan TL, Dinh XS, Pham PL, Ly VC, Tran TH, Nguyen TH, Bethell DB, Nguyan HP, et al. Blood 1996 88 4694 4700 8977263 (Pubitemid 26419154)
19. Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance. Simpson JA, Watkins ER, Price RN, Aarons L, Kyle DE, White NJ, Antimicrob Agents Chemother 2000 44 3414 3424 10.1128/AAC.44.12.3414- 3424.2000 11083649 (Pubitemid 33009503)
20. Estimation of relationships of limited dependent variables. Tobin J, Econometrica 1958 26 24 36 10.2307/1907382
21. A new look at the statistical model identification. Akaike H, IEEE Transactions on Automatic Control 1974 19 716 723 10.1109/TAC.1974.1100705